Overview

Open Label Extension for GLYX13-C-202, NCT01684163

Status:
Terminated
Trial end date:
2018-11-08
Target enrollment:
Participant gender:
Summary
Examine the safety of long term repeat exposure to GLYX-13 in subjects who participated in GLYX13-C-202.
Phase:
Phase 2
Details
Lead Sponsor:
Naurex, Inc
Naurex, Inc, an affiliate of Allergan plc